Literature DB >> 20821801

Deconstructing acrophobia: physiological and psychological precursors to developing a fear of heights.

Carlos M Coelho1, Guy Wallis.   

Abstract

BACKGROUND: Acrophobia is one of the most prevalent phobias, affecting as many as 1 in 20 individuals. Of course, heights often evoke fear in the general population too, and this suggests that acrophobia might actually represent the hypersensitive manifestation of an everyday, rational fear. In this study, we assessed the role of sensory and cognitive variables in acrophobia.
METHODS: Forty-five participants (Mean age 25.07 years, 71% female) were assessed using a booklet with self-reports as well as several behavioral measures. The data analysis consisted in multivariate linear regression using fear of heights as the outcome variable.
RESULTS: The regression analyses found that visual field dependence (measured with the rod and frame test), postural control (measured with the Sharpened Romberg Test), space and motion discomfort (measured with the Situational Characteristics Questionnaire), and bodily symptoms (measured with the Bodily Sensation Questionnaire) all serve as strong predictors for fear of heights (Adjusted r(2)=.697, P<.0001). Trait anxiety (measured with the State Trait Anxiety Inventory Form Y-2) was not related with fear of heights, suggesting that this higher order vulnerability factor is not necessary for explaining this particular specific phobia in a large number of individuals.
CONCLUSION: The findings reveal that fear of heights is an expression of a largely sensory phenomena, which can produce strong feelings of discomfort and fear in the otherwise calm individuals. We propose a theory that embraces all these factors and provides new insight into the aetiology and treatment of this prevalent and debilitating fear. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20821801     DOI: 10.1002/da.20698

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  11 in total

1.  [How acrophobia impairs visual exploration and gait].

Authors:  G Kugler; D Huppert; E Schneider; T Brandt
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

2.  Visual height intolerance and acrophobia: clinical characteristics and comorbidity patterns.

Authors:  Hans-Peter Kapfhammer; Doreen Huppert; Eva Grill; Werner Fitz; Thomas Brandt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-28       Impact factor: 5.270

3.  Representation of Fear of Heights by Basolateral Amygdala Neurons.

Authors:  Jun Liu; Longnian Lin; Dong V Wang
Journal:  J Neurosci       Date:  2021-01-12       Impact factor: 6.167

4.  No bridge too high: infants decide whether to cross based on the probability of falling not the severity of the potential fall.

Authors:  Kari S Kretch; Karen E Adolph
Journal:  Dev Sci       Date:  2013-02-09

5.  Down on heights? One in three has visual height intolerance.

Authors:  Doreen Huppert; Eva Grill; Thomas Brandt
Journal:  J Neurol       Date:  2012-10-16       Impact factor: 4.849

6.  Visual field dependence as a navigational strategy.

Authors:  Chéla R Willey; Russell E Jackson
Journal:  Atten Percept Psychophys       Date:  2014-05       Impact factor: 2.199

7.  Self-efficacy beliefs are associated with visual height intolerance: a cross-sectional survey.

Authors:  Eva Grill; Florian Schäffler; Doreen Huppert; Martin Müller; Hans-Peter Kapfhammer; Thomas Brandt
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

8.  A genome-wide screen for acrophobia susceptibility loci in a Finnish isolate.

Authors:  Zuzanna Misiewicz; Tero Hiekkalinna; Tiina Paunio; Teppo Varilo; Joseph D Terwilliger; Timo Partonen; Iiris Hovatta
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

9.  A Cognitive-Behavior Therapy Applied to a Social Anxiety Disorder and a Specific Phobia, Case Study.

Authors:  George D Tsitsas; Antonia A Paschali
Journal:  Health Psychol Res       Date:  2014-10-21

10.  Brain metabolism and related connectivity in patients with acrophobia treated by virtual reality therapy: an 18F-FDG PET pilot study sensitized by virtual exposure.

Authors:  Antoine Verger; Eric Malbos; Emmanuelle Reynaud; Pierre Mallet; Daniel Mestre; Jean-Marie Pergandi; Stéphanie Khalfa; Eric Guedj
Journal:  EJNMMI Res       Date:  2018-10-01       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.